用色素5-HT1A受体部分激素增强疗法对抑郁症患者的认知功能:随机对照研究的系统审查
Risa Yamada1,2, Ayumu Wada1,2, Andrew Stickley1
1Department of Preventive Intervention for Psychiatric Disorders, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
Neuropsychopharmacology reports
|May 27, 2025
概括
辅助色胺5-HT1A受体部分激动剂 (5-HT1A-PAs) 在改善严重抑郁症和血管抑郁症的认知缺陷方面表现有前途. 需要进一步的研究来探索新型激动剂,以获得增强的认知效益.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 血清素5-HT1A受体部分激动剂 (5-HT1A-PAs) 在情绪障碍和认知功能中的作用被探索.
- 有证据表明,5-HT1A受体刺激可能加速抗抑郁药物的作用.
- 本综述研究了辅助5-HT1A-PAs在改善抑郁症状患者的认知功能方面的疗效.
结论:
- 附加的5-HT1A-PAs在改善特定抑郁症障碍的认知缺陷方面具有潜力.
- 对新型5-HT1A受体激动剂的进一步研究是有必要的,因为它可能会带来更大的认知益处.
- 这些发现强调了针对5-HT1A途径用于情绪障碍的认知增强的治疗潜力.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
380
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
380
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
421
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
421
Antidepressant Drugs: Overview
804
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
804
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
626
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
626
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
214
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
214
G-protein Coupled Receptors
121.8K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
121.8K


